CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Amphotericin B

两性霉素B 杂质对照品Amphotericin B Impurities

EPChP17 个杂质条目17 impurity entries

本页汇总 两性霉素B 的 17 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 17 impurity reference standards of Amphotericin B with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 两性霉素B(Amphotericin B)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studies[Impurity profile analysis of amphotericin B using on-line two-dimensional high performance liquid chromatography-quadrupole time-of-flight mass spectrometry]
    Se pu = Chinese journal of chromatography · 2024 · Weng RW et al.  ·  PMID 38736386  ·  DOI
  2. 杂质研究Impurity studiesEvidence that impurities contribute to the fluorescence of the polyene antibiotic amphotericin B
    The Journal of antimicrobial chemotherapy · 2009 · Bolard J et al.  ·  PMID 19258352  ·  DOI
  3. 杂质研究Impurity studiesIsolation, structure elucidation and activity of an unknown impurity of amphotericin B
    The Journal of antibiotics · 2007 · Li J et al.  ·  PMID 17456979  ·  DOI
  4. 分析方法Analytical MethodsHPLC assay for determination of amphotericin B in biological samples
    Biomedical chromatography : BMC · 2008 · Espada R et al.  ·  PMID 18059059  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisRibosomal synthesis of an amphotericin-B inspired macrocycle
    Journal of the American Chemical Society · 2014 · Torikai K, Suga H  ·  PMID 25454254  ·  DOI

两性霉素B —— 原料药与杂质对照品Amphotericin B — drug substance & impurities

共 18 个条目(含原料药本体)18 items incl. the drug substance
Amphotericin B structure
EP原料药 APIAPI
两性霉素BAmphotericin B
Amphotericin B
CAS No.1397-89-3
Chemical FormulaC47H73NO17
Purity>95%询价On request
10mg25mg50mg100mg
Amphotericin B Impurity 1 (Amphotericin B EP ImpurityA) (Amphotericin A)(28, 29-Dihydro-Amphotericin B) structure
EPA
两性霉素B杂质1 (两性霉素B EP杂质A)(两性霉素 A)(28, 29-二氢-两性霉素B)Amphotericin B Impurity 1 (Amphotericin B EP ImpurityA) (Amphotericin A)(28, 29-Dihydro-Amphotericin B)
Amphotericin B Impurity 1 (Amphotericin B EP ImpurityA) (Amphotericin A)(28, 29-Dihydro-Amphotericin B)
CAS No.1405-32-9
Chemical FormulaC47H75NO17
Purity>95%询价On request
10mg25mg50mg100mg
Amphotericin B Impurity 2 (Amphotericin B EP Impurity B)(Amphotericin X1)(13-O-Methyl Amphotericin B) structure
EPB
两性霉素B杂质2 (两性霉素B EP杂质B) (两性霉素 X1)(13-O-甲基 两性霉素B)Amphotericin B Impurity 2 (Amphotericin B EP Impurity B)(Amphotericin X1)(13-O-Methyl Amphotericin B)
Amphotericin B Impurity 2 (Amphotericin B EP Impurity B)(Amphotericin X1)(13-O-Methyl Amphotericin B)
CAS No.136135-57-4
Chemical FormulaC48H75NO17
Purity>95%询价On request
10mg25mg50mg100mg
Amphotericin B Impurity 19 (Amphotericin B ChP Impurity D) structure
ChPD
两性霉素B杂质19 (两性霉素B ChP杂质D)Amphotericin B Impurity 19 (Amphotericin B ChP Impurity D)
Amphotericin B Impurity 19 (Amphotericin B ChP Impurity D)
CAS No.944242-31-3
Chemical FormulaC48H75NO17
Purity>95%询价On request
10mg25mg50mg100mg
Amphotericin B Impurity 20 (Amphotericin B ChP Impurity E) structure
ChPE
两性霉素B杂质20 (两性霉素B ChP杂质E)Amphotericin B Impurity 20 (Amphotericin B ChP Impurity E)
Amphotericin B Impurity 20 (Amphotericin B ChP Impurity E)
CAS No.1314099-20-1
Chemical FormulaC48H73NO18
Purity>95%询价On request
10mg25mg50mg100mg
Amphotericin B Impurity 4 (Amphotericin B Methyl Ester) structure
4
两性霉素B杂质4(两性霉素B 甲酯)Amphotericin B Impurity 4 (Amphotericin B Methyl Ester)
Amphotericin B Impurity 4 (Amphotericin B Methyl Ester)
CAS No.36148-89-7
Chemical FormulaC48H75NO17
Purity>95%询价On request
10mg25mg50mg100mg
Amphotericin B Impurity 5 (Amphotericin A21) structure
5
两性霉素B杂质5(两性霉素 A21)Amphotericin B Impurity 5 (Amphotericin A21)
Amphotericin B Impurity 5 (Amphotericin A21)
CAS No.1383659-59-3
Chemical FormulaC54H82N4O18
Purity>95%询价On request
10mg25mg50mg100mg
Amphotericin B Impurity 6 (Amphoteronolide B) structure
6
两性霉素B杂质6(两性霉素B杂质M)(两性霉素B)Amphotericin B Impurity 6 (Amphoteronolide B)
Amphotericin B Impurity 6 (Amphoteronolide B)
CAS No.106799-07-9
Chemical FormulaC41H62O14
Purity>95%询价On request
10mg25mg50mg100mg
Amphotericin B  Impurity 13 structure
13
两性霉素B杂质13Amphotericin B Impurity 13
Amphotericin B Impurity 13
CAS No.902457-23-2
Chemical FormulaC49H75NO18
Purity>95%询价On request
10mg25mg50mg100mg
Amphotericin B  Impurity 14 structure
14
两性霉素B杂质14Amphotericin B Impurity 14
Amphotericin B Impurity 14
CAS No.1561-07-5
Chemical FormulaC15H32O3
Purity>95%询价On request
10mg25mg50mg100mg
Amphotericin B  Impurity 15 structure
15
两性霉素B杂质15Amphotericin B Impurity 15
Amphotericin B Impurity 15
CAS No.117089-03-9
Chemical FormulaC18H36O3
Purity>95%询价On request
10mg25mg50mg100mg
Amphotericin B Impurity 16 structure
16
两性霉素B杂质16Amphotericin B Impurity 16
Amphotericin B Impurity 16
CAS No.113676-50-9
Chemical FormulaC12H26O3
Purity>95%询价On request
10mg25mg50mg100mg
Amphotericin B Impurity 28 structure
28
两性霉素B杂质28Amphotericin B Impurity 28
Amphotericin B Impurity 28
CAS No.2165357-21-9
Chemical FormulaC54H85NO20
Purity>95%询价On request
10mg25mg50mg100mg
Amphotericin B Impurity 30 structure
30
两性霉素B杂质30Amphotericin B Impurity 30
Amphotericin B Impurity 30
CAS No.37371-05-4
Chemical FormulaC53H85NO19
Purity>95%询价On request
10mg25mg50mg100mg
Amphotericin B Impurity 34 structure
34
两性霉素B杂质34Amphotericin B Impurity 34
Amphotericin B Impurity 34
CAS No.136135-61-0
Chemical FormulaC49H77NO18
Purity>95%询价On request
10mg25mg50mg100mg
Amphotericin B Impurity 35 structure
35
两性霉素B杂质35Amphotericin B Impurity 35
Amphotericin B Impurity 35
CAS No.1228440-88-7
Chemical FormulaC47H72O18
Purity>95%询价On request
10mg25mg50mg100mg
Amphotericin B Impurity 36 structure
36
两性霉素B杂质36Amphotericin B Impurity 36
Amphotericin B Impurity 36
CAS No.1046146-54-6
Chemical FormulaC47H71NO17
Purity>95%询价On request
10mg25mg50mg100mg
Amphotericin B Impurity 37 structure
37
两性霉素B杂质37Amphotericin B Impurity 37
Amphotericin B Impurity 37
CAS No.127970-73-4
Chemical FormulaC47H71NO16
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

两性霉素B —— 研究文献与合成路线Amphotericin B — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 两性霉素B 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Amphotericin B. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Unveiling the Amphotericin B Degradation Pathway and Its Kinetics in Lipid-Based Solutions
    Alencar ÉN, Sawangchan P, Kirsch LE, et al. · Journal of pharmaceutical sciences · 2021 · 被引 10cited 10
  2. Acute immune hemolysis induced by a degradation product of amphotericin B
    Salama A, Burger M, Mueller-Eckhardt C · Blut · 1989 · 被引 13cited 13
  3. Evidence that impurities contribute to the fluorescence of the polyene antibiotic amphotericin B
    Bolard J, Cleary JD, Kramer RE · The Journal of antimicrobial chemotherapy · 2009 · 被引 6cited 6
  4. Characterizing the Complex Multi-Step Degradation Kinetics of Amphotericin B in a Microemulsified Drug Delivery System
    Santos SRA, Alencar ÉN, Urtiga SCC, et al. · AAPS PharmSciTech · 2025
  5. [Impurity profile analysis of amphotericin B using on-line two-dimensional high performance liquid chromatography-quadrupole time-of-flight mass spectrometry]
    Weng RW, Wang XT, Wen HL, et al. · Se pu = Chinese journal of chromatography · 2024
  6. Quantitative determination of impurities in polyene antibiotics: Fourier transform Raman spectra of nystatin, amphotericin A, and amphotericin B
    Lewis EN, Kalasinsky VF, Levin IW · Analytical chemistry · 1988 · 被引 5cited 5

合成与制备工艺专利Synthesis & process patents

  1. SUBSTAINED RELEASE HYDROGELS COMPRISING AMPHOTERICIN B AND PREPARATION METHOD THEREOF
    PARK JEONG SOOK, SHIN BAEK KI, KIM YE TAE, HUH KANG MOO, et al. · 公开号 KR20120015573KR20120015573 · 2012
  2. PROCESS FOR PREPARING PEGYLATED AMPHOTERICIN B DERIVATIVES
    KIM JOON SEOP, KIM JONG MIN, KIM HYOUNG SHIK · 公开号 KR100821693BKR100821693B · 2008
  3. Long-acting preparation containing amphotericin B
    WENFANG ZHANG · 公开号 CN101450039CN101450039 · 2009
  4. Freeze-drying preparation containing amphotericin B
    WENFANG ZHANG · 公开号 CN101450045CN101450045 · 2009
  5. Amphotericin B nano preparation
    CHEN JIANGHAN WEN · 公开号 CN1850032CN1850032 · 2006

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

两性霉素B 杂质谱研究要点Amphotericin B — impurity profiling notes

下面这些是拿到 两性霉素B 的 18 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 18 impurity entries for Amphotericin B, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances